Yu Rang Park2019년 6월 26일1분 분량A new paper published to Tumori Journal in Mar. 2019 Kwon, Byoung Soo, et al. "Survival benefit of first-generation epidermal growth factor receptor–tyrosine kinase inhibitors in female with advanced lung cancer." Tumori Journal (2019): 0300891619839292. https://www.ncbi.nlm.nih.gov/pubmed/30905312
Kwon, Byoung Soo, et al. "Survival benefit of first-generation epidermal growth factor receptor–tyrosine kinase inhibitors in female with advanced lung cancer." Tumori Journal (2019): 0300891619839292. https://www.ncbi.nlm.nih.gov/pubmed/30905312
Received new grant from MIST and MOHW (Total budget: 700 million won, 3 years) in July 2019In July 2019, DHLab obtained a national grant on Development of artificial intelligence based drug surveillance system ordered by MIST (...
Comments